Production
and Characterization of Monochlorinated and Dechlorinated A40926 Derivatives
Vicuron Pharmaceuticals via R. Lepetit, 34, 21040, Gerenzano (Varese) Italy (Received for publication April 11, 2003) Nonomuraed sp. ATCC 39727 is the producer of the A40926 complex of lipoglycopeptide antibiotics which contain chlorine atoms in amino acids 3 and 6 of the peptide backbone. Using a classical mutagenesis and selection approach we have isolated a Nonomuraea sp. ATCC 39727 mutant strain able to direct production towards new A40926 analogues dechloro-A40926 (DDC) lacking two chlorine atoms and the two monochloro-A40926 (MDC1 and MDC2) that are not produced fermenting the wild type strain. Dechlorinated A40926 derivatives were obtained in considerable amount in a standard fermentation process and were purified and chemically characterized. The dechlorinated A40926 derivatives DDC and MDC2 showed improved antimicrobial activity against coagulase negative staphylococci strains in respect to A40926 complex. Dechlorinated derivatives of the related antibiotic teicoplanin are also reported in the literature and are generally less active than the parental products. (Figure 1 ). Several structural analogues have been identified in the A40926 complex19,20).
The two major components of the complex, named B0
(formerly B) and B1, are characterized respectively by an iso-C12:0 and a n-C12:0 acylic moiety bound to the aminoglucuronic acid of the antibiotic (Figure 1 by HPLC as below described.
A40926, DDC, MDCl and MDC2 were extracted from the broth and purified for LC-MS and antibiotic activity assays as follows. D-alanyl-D-alanine-aminocaproyl Sepharose CL-6B was used as affinity resin as already described24). The packed resin was equilibrated with 0.2M NaCl in 0.05M NaH2PO4 pH 7.5 prior to mixing with prefiltered fermentation broth prepared as above described and brought at pH 7.5 with HCl 1M. The antibiotics, selectively bound to the resins were washed with 0.2M NaCl in 0.05M NaH2PO4 pH 7.5 and eluted with 1.5% NH4OH.
The samples were vacuum dried and resuspended in an About 12000 clones from a mutagenized sample of Nonomuraea sp. ATCC 39727 were plated on SM agar medium and tested by overlay with S. haemolyticus 3902 (clinical isolate, teicoplanin resistant). In this condition, the parental strain, which is able to produce the antibiotic A40926, was unable to give inhibition halos on S.
haemolyticus. This overlay screening was in fact set up to select those mutants producing markedly more antibiotic and/or giving more active components in the A40926 complex. Among the tested clones one able to give an inhibition halo on S. haemolyticus 3902 was named A40DC
and resulted phenotypically undistinguishable from the parental strain. Fermentation experiments and subsequent HPLC analysis evidenced the presence of a complex of compounds ( Figure   2 ) not present in the fermentation broth of Nonomuraea sp.
ATCC 39727 producer of the A40926 complex. In strain A40DC the main peaks were at retention times 15.6 (MDCl), 18.9 (DDC) and 21.5 (MDC2) (Figure 2 ) while factor B0 (peak retention time of 17.5 minutes) was present in low concentration.
Chemical Characterization of Dechlorinated A40926
Derivatives
The fermentation broth of strain A40DC was purified by binding to D-alanyl-D-alanine-aminocaproyl Sepharose CL-6B resins and the mixture eluted from the resin maintained the complex composition as in the fermentation broth. The sample was analysed by LC-MS and the fractions showed a m/z main peak of 1697 (MDC1), 1732.5 (B0-A40926), 1663 (DDC) and 1697 (MDC2) respectively. The loss of 35 mass units in samples MDC1 and MDC2 was consistent with loss of one chlorine atom from either aminoacids 3 or 6 in the B0-A40926 molecule and loss of 70 mass units in DDC suggested the loss of both chlorine atoms. In Nonomuraea sp. ATCC 39727 fermentations, the formulation of the medium T/2 (see Materials and Methods) boost the production of B0 factor (iso-C12:0 N- 
MDC1, monochloro-A40926
(chlorine is bound to aminoacid number 6); B0-A40926, B0 factor of A40926 antibiotic; DDC, dechloro-A40926; MDC2, monochloro-A40926 (chlorine is bound to aminoacid number 3). inactivation of the halogenase gene yielded a dechlorinated derivative that was identical to balhimycin in the rest of the structure suggesting that halogenation was not a precondition for subsequent biosynthesis steps. A similar situation was observed in Nonomuraea sp. In fact, the dechlorinated derivatives present in the fermentation broths of strain A40DC consisted of two monochloro-, the dechloro-and the B0-A40926 molecules, thus suggesting the presence of a single, partially inactivated halogenase enzyme able to yield all the possible combinations in the loss of the two chlorine atoms. Furthermore, the occurrence in the fermentation broth of Nonomuraea sp. A40DC of a dechloro mixture, which is identical in the rest of the structure to the A40926 antibiotic, suggested that biosynthesis occurs independently from the presence of chlorine in the molecule. We have found that two out of three dechlorinated A40926 derivatives (DDC and MDC2) have improved microbiological activity against some clinically relevant microorganisms. In the cases of the corresponding teicoplanin derivatives, MALABARBA et al.14) reported that the loss of chlorine bound at aminoacid number 2 or of both chlorines of teicoplanin decreased the binding affinity for the D-alanyl-D-alanine target of the antibiotic. This was correlated with a consequent marked reduction of in vitro and in vivo antimicrobial activity. HARRIS et al.13) reported similar results for vancomycin and suggested that chlorine contributes to the stability and the specificity of the binding to the target.
We have evidenced by MS studies a dimerizing capacity of dechlore A40926 (DDC) improved with respect to that of A40926 (M. FEROGGIO, unpublished result). This dimerization capacity is peculiar of some glycopetides and was extensively studied as a determinant of their antimicrobial effectiveness27). In the case of DDC molecules the influence of the loss of the bulky, electronegative chlorine could facilitate the dimerizing reaction resulting in an increase of antimicrobial activity.
